Chronic subcutaneous leptin infusion diminishes the responsiveness of the hypothalamic–pituitary–adrenal (HPA) axis in female rhesus monkeys

2005 ◽  
Vol 84 (3) ◽  
pp. 449-458 ◽  
Author(s):  
Mark E. Wilson ◽  
Jeffrey Fisher ◽  
Juliet Brown
Endocrine ◽  
2005 ◽  
Vol 26 (2) ◽  
pp. 089-098 ◽  
Author(s):  
Mark E. Wilson ◽  
Ariadne Legendre ◽  
Karen Pazol ◽  
Jeffrey Fisher ◽  
Kathy Chikazawa

2012 ◽  
Vol 62 (4) ◽  
pp. 389-399 ◽  
Author(s):  
Vasiliki Michopoulos ◽  
Katherine M. Reding ◽  
Mark E. Wilson ◽  
Donna Toufexis

2004 ◽  
Vol 36 (05) ◽  
Author(s):  
D Eser ◽  
P Zwanzger ◽  
S Aicher ◽  
C Schüle ◽  
TC Baghai ◽  
...  

2021 ◽  
Vol 3 (3) ◽  
pp. 403-408
Author(s):  
Athanasios Tselebis ◽  
Emmanouil Zoumakis ◽  
Ioannis Ilias

In this concise review, we present an overview of research on dream recall/affect and of the hypothalamic–pituitary–adrenal (HPA) axis, discussing caveats regarding the action of hormones of the HPA axis (mainly cortisol and its free form, cortisol-binding globulin and glucocorticoid receptors). We present results of studies regarding dream recall/affect and the HPA axis under physiological (such as waking) or pathological conditions (such as in Cushing’s syndrome or stressful situations). Finally, we try to integrate the effect of the current COVID-19 situation with dream recall/affect vis-à-vis the HPA axis.


Pain Medicine ◽  
2021 ◽  
Vol 22 (4) ◽  
pp. 994-1000
Author(s):  
Haewon Lee ◽  
Jennifer A Punt ◽  
David C Miller ◽  
Ameet Nagpal ◽  
Clark C Smith ◽  
...  

Abstract Myth Corticosteroid injection for the treatment of pain and inflammation is known to decrease the efficacy of the messenger ribonucleic acid (mRNA) vaccines for coronavirus disease 2019 (COVID-19). Fact There is currently no direct evidence to suggest that a corticosteroid injection before or after the administration of an mRNA COVID-19 vaccine decreases the efficacy of the vaccine. However, based on the known timeline of hypothalamic-pituitary-adrenal (HPA) axis suppression following epidural and intraarticular corticosteroid injections, and the timeline of the reported peak efficacy of the Pfizer-BioNTech and Moderna vaccines, physicians should consider timing an elective corticosteroid injection such that it is administered no less than 2 weeks prior to a COVID-19 mRNA vaccine dose and no less than 1 week following a COVID-19 mRNA vaccine dose, whenever possible.


Sign in / Sign up

Export Citation Format

Share Document